QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

35,144 signal articles · 106 in last 24h · 178,660 total before filter · latest 1h ago

106last 24h

3125last 7d

511● bullish (7d)

311● bearish (7d)

227publishers

All Macro103 Earnings1819 M&A172 Regulatory23 Product26 Analyst28

✕ clear all filtersticker: ABBVsentiment: neutralSentiment:bullish neutral bearish show all (incl. clickbait)

MT Newswires2d agoneutral

Argus Adjusts Price Target on AbbVie to $320 From $270

MT Newswires5d agoneutral

BNP Paribas Adjusts Price Target on AbbVie to $269 From $247

MT Newswires6d agoneutral

Canaccord Genuity Adjusts Price Target on AbbVie to $338 From $290

MT Newswires6d agoneutral

Leerink Partners Adjusts Price Target on AbbVie to $325 From $279

MT Newswires6d agoneutral

Goldman Sachs Adjusts Price Target on AbbVie to $313 From $294

MT Newswires6d agoneutral

Cantor Fitzgerald Adjusts Price Target on AbbVie to $325 From $290

MT Newswires6d agoneutral

Guggenheim Adjusts Price Target on AbbVie to $322 From $288

24/7 Wall St.39d agoneutral

BofA Boosts AbbVie and J&J Price Targets on Growth and Pipeline Strength

24/7 Wall St.80d agoneutral

Dividend Giants Pfizer, Chevron, AbbVie: Bold 2027 Price Targets Ahead

ABBV CVX MSFT PFE